MCDERMOTT+ LLC

Lobbying for 340B HEALTH · Association focusing on the 340B drug pricing program

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $40,000.00 income · posted Apr 10, 2026

Lobbying activity 2

Health Issues

Issues relating to the 340B Drug Pricing Program.

Medicare/Medicaid

Issues relating to the 340B Drug Pricing Program.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.